A calprotectin stool test may help determine whether you have an inflammatory or noninflammatory bowel condition. The information it provides may also eliminate the need for more invasive tests. Share ...

To best detect the presence of colorectal cancer, patients must undergo a colonoscopy – an invasive procedure that examines the rectum and entire colon. However, the exam is only performed once every ...

October 9, 2008 — Stool DNA testing is a new approach to screening for colorectal cancer, but it is an evolving technology. A study has found that the first-generation stool DNA test (SDT-1) is not ...

An investigational multitarget stool DNA test for screening colorectal cancer detects significantly more cancers than the currently available fecal immunochemical test (FIT), researchers report. But ...

To best detect the presence of colorectal cancer, patients must undergo a colonoscopy—an invasive procedure that examines the rectum and entire colon. However, the exam is typically only performed ...

Scientists continue to push for the development of a more precise, sensitive and cleaner colorectal cancer diagnostic. Now a research team from the University of California, San Francisco, and Kaiser ...

Please provide your email address to receive an email when new articles are posted on . Multi-target stool DNA screening tests predicted neoplasia at follow-up colonoscopy more often than fecal ...

A test for fecal occult blood looks for blood in your poop, or feces. It can be a sign of a problem in your digestive system, such as a growth, or polyp, or cancer in the colon or rectum. If the ...

Lindsay Curtis is a health & medical writer in South Florida. She worked as a communications professional for health nonprofits and the University of Toronto’s Faculty of Medicine and Faculty of ...

The U.S. Preventive Services Task Force recommends colorectal cancer screening for all adults starting at age 45. After age 75, the task force recommends talking with your health care team to decide ...

Commercial FITs can match NG-MSDT diagnostic results for CRC by lowering the positivity threshold, enhancing sensitivity while maintaining specificity. FITs are accessible, noninvasive CRC screening ...